ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |
| Auour Investments LLC | 177,000 | $534,540 | 0.23% |
| Acuitas Investments, LLC | 123,427 | $370,281 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 278,286 | $835 | 0.07% |
| Virtus ETF Advisers LLC | 24,183 | $72,549 | 0.04% |
| RBF Capital, LLC | 152,416 | $457,248 | 0.03% |
| Anson Funds Management LP | 50,000 | $150,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 379,912 | $1,139,736 | 0.03% |
| Shay Capital LLC | 48,635 | $145,905 | 0.02% |
| DENALI ADVISORS LLC | 18,000 | $54,000 | 0.02% |
| Marquette Asset Management, LLC | 24,865 | $74,595 | 0.02% |
External links
This page lists ATEA PHARMACEUTICALS INC's shareholders in Q3 2023. To view ATEA PHARMACEUTICALS INC's shareholder history, click here.